Jeffrey Ubben
ValueAct Holdings
ValueAct Holdings Portfolio 13F
Jeffrey Ubben Holdings Activity
- Portfolio value:
- $15.96B≈ (+$1B≈)
- Previous value:
- $14.92B≈
- # of changes:
- 12
- New positions:
- 2
- Reported for:
- 31 Dec 2014 (Q4)
- Latest filing date:
- 17 Feb 2015
ValueAct Holdings has disclosed a total of 12 changes to the portfolio in the (2014 Q4) SEC report(s): increased the number of shares of 5, bought 2 totally new, decreased the number of shares of 4 and completely sold out 1 position(s).
What stocks did Jeffrey Ubben buy in 2014 Q4?
During 2014 Q4 Jeffrey Ubben has bought 7 securities out of which top 5 purchases (by % change to portfolio) were (MSFT) Microsoft Corp (reduced shares 0.00%), (VRX) Valeant Pharmaceuticals International Inc (added shares +2.43%), (FOX) Fox Corp, CL-B (added shares +20.24%), (BHI) Baker Hughes Inc (new buy) and (HAL) Halliburton Company (new buy).
What did Jeffrey Ubben invest in during 2014 Q4?
In the 2014 Q4 report(s) the following changes have been made to the top investments: (MSFT) Microsoft Corp (reduced shares 0.00%), (VRX) Valeant Pharmaceuticals International Inc (added shares +2.43%), (MSI) Motorola Solutions Inc (reduced shares -39.16%), (ADBE) Adobe Systems Incorporated (reduced shares -32.91%) and (FOX) Fox Corp, CL-B (added shares +20.24%).
12 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Baker Hughes Inc
|
new
|
$56.07
|
|
5.27%
|
2014 Q4
|
≈ 0.25 years
|
||||
|
|
Halliburton Company
|
new
|
$39.33
|
-18.98%($31.86)
|
5.15%
|
2014 Q4
|
≈ 0.25 years
|
||||
|
|
AGRIUM INC
|
+57.09%
|
$94.72
|
|
4.86%
|
2014 Q3
|
≈ 0.50 years
|
||||
|
|
Fox Corp, CL-B
|
+20.24%
|
$36.89
|
+40.88%($51.97)
|
7.00%
|
2014 Q2
|
≈ 0.75 years
|
||||
|
|
Allison Transmission Holdings Inc
|
+6.10%
|
$33.90
|
+252.04%($119.34)
|
4.06%
|
2013 Q3
|
≈ 1.50 years
|
||||
|
|
Valeant Pharmaceuticals International Inc
|
+2.43%
|
$143.11
|
|
17.38%
|
2013 Q2 or earlier
|
≈ 1.75+ years
|
||||
|
|
Microsoft Corp
|
+0.00%
|
$46.45
|
+951.45%($488.40)
|
21.61%
|
2013 Q2 or earlier
|
≈ 1.75+ years
|
||||
|
|
CBRE Group Inc, CL-A
|
-2.62%
|
$34.25
|
+341.37%($151.17)
|
6.72%
|
2013 Q2 or earlier
|
≈ 1.75+ years
|
||||
|
|
Adobe Systems Incorporated
|
-32.91%
|
$72.70
|
+255.20%($258.23)
|
7.29%
|
2013 Q2 or earlier
|
≈ 1.75+ years
|
||||
|
|
Motorola Solutions Inc
|
-39.16%
|
$67.08
|
+556.31%($440.25)
|
7.39%
|
2013 Q2 or earlier
|
≈ 1.75+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.